Haemophilus Influenzae Pneumonia — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for haemophilus influenzae pneumonia. 22 active patents protecting 3 drugs from 3+ originators. First major cliff: 2030. Daily refresh.

3
Approved drugs
22
Active US patents
56/100
Avg vulnerability
—
Annual revenue covered

Originators in Haemophilus Influenzae Pneumonia

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Generic (originally Beecham/GSK) 14 patents AbbVie 4 patents Fresenius Kabi 4 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating haemophilus influenzae pneumonia. Each bar = one year. Y-axis scaled to peak year (7 patents).

2
26
1
27
1
28
1
29
7
30
2
31
1
33
6
34

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Amoxil
amoxicillin
 Generic (originally Beecham/GSK) 14 58 — 2026-12-08
Teflaro
CEFTAROLINE FOSAMIL
 AbbVie 4 61 — 2030-09-21
Tygacil
TIGECYCLINE
 Fresenius Kabi 4 49 — 2028-10-24

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
8299052 Amoxil method of use 85 2027-05-07
8778924 Amoxil method of use 80 2026-12-08
11931463 Amoxil method of use 75 2034-02-12
11878011 Amoxil method of use 75 2042-05-27
8247400 Teflaro method of use 73 2031-02-10
8247400 Teflaro method of use 73 2031-02-10
8357394 Amoxil formulation 65 2026-12-08
9050263 Amoxil method of use 62 2034-02-12
11135172 Amoxil method of use 62 2034-02-12
9603806 Amoxil method of use 62 2034-02-12

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
7977488 Amoxil composition of matter 18 2030-04-10
7977488 Amoxil composition of matter 18 2030-04-10
10238606 Amoxil formulation 42 2034-02-12
9855335 Tygacil formulation 42 2033-04-07
9629861 Teflaro formulation 48 2030-09-21
9629861 Teflaro formulation 48 2030-09-21
8372995 Tygacil formulation 53 2030-10-08
8975242 Tygacil formulation 55 2028-10-24
9186411 Amoxil formulation 56 2030-08-11
9186411 Amoxil formulation 56 2030-08-11

Related